電訊股普漲 中國聯通(0762.HK)大漲5%
格隆匯9月14日丨港股電訊股普漲,其中,中國聯通(0762.HK)漲5%領漲,電訊盈科、和記電訊香港和中國電信漲超1%,中國移動、香港電訊、香港寬頻均處於上漲中。高盛維持中國聯通買入評級,目標價7.5港元。中國電信與中國聯通近日在京舉行了5G網絡共建共享一週年工作回顧總結暨全面深化共建共享合作推進會議。通過共建共享,一年時間雙方累計建設開通5G基站超30萬站,5G網絡覆蓋擴大至全國所有地級及以上城市,節省建設投資超600億元。雙方還表示將共同推動獨立組網(SA)產業鏈成熟完善,力爭9月30日前具備SA商用基礎網絡能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.